Testing effectiveness (Phase 2)Ended earlyNCT04218825
What this trial is testing
REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
Who this might be right for
Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
European Organisation for Research and Treatment of Cancer - EORTC 2